Tamoxifen and risk of large bowel cancer in women with breast cancer

被引：0
|
作者：
Polly A. Newcomb
Cam Solomon
Emily White
机构：
[1] Fred Hutchinson Cancer Research Center,Cancer Prevention Research Program
来源：
Breast Cancer Research and Treatment | 1999年 / 53卷
关键词：
breast neoplasms; therapy; colorectal neoplasms; estrogen antagonists; estrogen replacement therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: The increasingly consistent association between estrogen replacement therapy and colorectal cancer suggests that the anti-estrogen tamoxifen may also be associated with large bowel cancer incidence.
引用
收藏
页码：271 / 277
页数：6
相关论文
共 50 条
  • [21] Effect of tamoxifen and aromatase inhibitors on the risk of fractures in women with breast cancer
    Vestergaard, Peter
    Rejnmark, Lars
    Mosekilde, Leif
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 (05) : 334 - 340
  • [22] TAMOXIFEN PROPHYLAXIS FOR WOMEN AT HIGH-RISK OF BREAST-CANCER
    GAZET, JC
    LANCET, 1985, 2 (8464): : 1119 - 1119
  • [23] Tamoxifen: risk of contralateral breast cancer
    Reactions Weekly, 2001, 875 (1) : 4 - 4
  • [24] Breast cancer: Risk, prevention, & tamoxifen
    Machia, J
    AMERICAN JOURNAL OF NURSING, 2001, 101 (04) : 26 - 35
  • [25] Tamoxifen therapy for breast cancer and endometrial cancer risk
    Bernstein, L
    Deapen, D
    Cerhan, JR
    Schwartz, SM
    Liff, J
    McGann-Maloney, E
    Perlman, JA
    Ford, L
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (19) : 1654 - 1662
  • [26] The tamoxifen paradoxinfluence of adjuvant tamoxifen on fracture risk in pre- and postmenopausal women with breast cancer
    Kyvernitakis, I.
    Kostev, K.
    Hadji, P.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 (11) : 2557 - 2564
  • [27] Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer
    Li, CI
    Malone, KE
    Weiss, NS
    Daling, JR
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (13) : 1008 - 1013
  • [28] Tamoxifen in women with breast cancer and mammographic density
    Meggiorini, M. L.
    Labi, L.
    Vestri, A. R.
    Porfiri, L. M.
    Savelli, S.
    De Felice, C.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2008, 29 (06) : 598 - 601
  • [29] Tamoxifen and fenretinide in women with metastatic breast cancer
    Zujewski, J
    Pai, L
    Wakefield, L
    Giusti, R
    Dorr, FA
    Flanders, C
    Caruso, R
    Kaiser, M
    Goodman, L
    Merino, M
    Gossard, M
    Noone, MA
    Denicoff, A
    Venzon, D
    Cowan, KH
    O'Shaughnessy, JA
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 57 (03) : 277 - 283
  • [30] Tamoxifen for breast cancer in hysterectomised women - Reply
    Veronesi, U
    Maisonneuve, P
    Rotmensz, N
    Boyle, P
    LANCET, 2002, 360 (9347): : 1785 - 1785
12345